Summary of Product Characteristics
last updated on the eMC:
04/04/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 04/04/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 21-Mar-2011 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Changes to the SmPC following the approval of the change in legal entity to MSD.
|
|
Updated on 04/12/2009 and displayed until 04/04/2011
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 6. 3 - Shelf Life
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Nov-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 4.6 - change of heading from "Pregnancy & lactation" to "Fertility, pregnancy & lactation"
Section 6.3 - increase of shelf life from 24 to 36 months for 500gm plastic jar with screw cap. 460gm pump dispenser pack removed
Section 6.5 - 500gm tube removed. 500gm polypropylene jar added. 460gm polypropylene piston pack removed.
Section 10 - Date of Revision of Text changed from July 2009 to November 2009
|
|
Updated on 14/09/2009 and displayed until 04/12/2009
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 01-Jul-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 4.8 changed from:
Rarely, mild skin reactions have occurred.
To:
Skin reactions including pruritus, rash, erythema, skin exfoliation, burning sensation, hypersensitivity, pain, dry skin and bullous dermatitis have been reported with product use.
|
|
Updated on 19/11/2007 and displayed until 14/09/2009
|
Reasons for adding or updating:
|
-
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 10/2007 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 9 and 10 updated to reflect renewal of product licence
|
|
Updated on 13/08/2003 and displayed until 19/11/2007
|
Reasons for adding or updating:
|
-
Change to section 6. 3 - Shelf Life
-
Change to section 6. 5 - Nature and Contents of Container
|
|
Updated on 20/08/2001 and displayed until 13/08/2003
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 26/07/2001 and displayed until 20/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 09/04/2001 and displayed until 26/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 09/04/2001
|
Reasons for adding or updating:
|
|
|
|